| Preview | Company (Stock code) | Event | Presenter |
|---|---|---|---|
 | SUMMIT THERAPEUTICS (SUMM) |
Summit Therapeutics - Initial trials of ridinilazole Mark Wilcox - Professor Thu, 10 Mar 2016 12:05 pm (UK time) |
|
| | SUMMIT THERAPEUTICS (SUMM) |
Summit Therapeutics - C. difficile Infection, a Recurring Problem Mark Wilcox - Professor Thu, 10 Mar 2016 12:00 pm (UK time) |
|
 | SUMMIT THERAPEUTICS (SUMM) |
Summit Therapeutics - Master Investor 2015 Richard Pye, Head of Investor Relations - Richard Pye, Head of Investor Relations Wed, 29 Apr 2015 11:30 am (UK time) |
|
 | SUMMIT THERAPEUTICS (SUMM) |
Summit Corporation - Phase 1b clinical trial in DMD patients Glyn Edwards - CEO Fri, 23 May 2014 05:40 am (UK time) |
|